Clinical Trial Update: Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial evaluating collagen membrane with human umbilical cord mesenchymal stem cells for nasal septum perforation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Septum Perforation

Drugs mentioned

• Collagen membrane combined with HUC-MSCs transplantation (collagen membrane; human umbilical cord mesenchymal stem cells (HUC-MSCs))

Snippet

Sponsor: Chinese Academy of Sciences | Conditions: Chronic Nasal Septum Perforation | Phase 1, Phase 2 | Status: UNKNOWN